Correlation Between DexCom and Elevai Labs,

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both DexCom and Elevai Labs, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining DexCom and Elevai Labs, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between DexCom Inc and Elevai Labs, Common, you can compare the effects of market volatilities on DexCom and Elevai Labs, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in DexCom with a short position of Elevai Labs,. Check out your portfolio center. Please also check ongoing floating volatility patterns of DexCom and Elevai Labs,.

Diversification Opportunities for DexCom and Elevai Labs,

-0.39
  Correlation Coefficient

Very good diversification

The 3 months correlation between DexCom and Elevai is -0.39. Overlapping area represents the amount of risk that can be diversified away by holding DexCom Inc and Elevai Labs, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Elevai Labs, Common and DexCom is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on DexCom Inc are associated (or correlated) with Elevai Labs,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Elevai Labs, Common has no effect on the direction of DexCom i.e., DexCom and Elevai Labs, go up and down completely randomly.

Pair Corralation between DexCom and Elevai Labs,

Given the investment horizon of 90 days DexCom Inc is expected to generate 0.36 times more return on investment than Elevai Labs,. However, DexCom Inc is 2.75 times less risky than Elevai Labs,. It trades about -0.02 of its potential returns per unit of risk. Elevai Labs, Common is currently generating about -0.16 per unit of risk. If you would invest  11,790  in DexCom Inc on September 4, 2024 and sell it today you would lose (3,699) from holding DexCom Inc or give up 31.37% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

DexCom Inc  vs.  Elevai Labs, Common

 Performance 
       Timeline  
DexCom Inc 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in DexCom Inc are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of very weak fundamental indicators, DexCom displayed solid returns over the last few months and may actually be approaching a breakup point.
Elevai Labs, Common 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Elevai Labs, Common has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

DexCom and Elevai Labs, Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with DexCom and Elevai Labs,

The main advantage of trading using opposite DexCom and Elevai Labs, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if DexCom position performs unexpectedly, Elevai Labs, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Elevai Labs, will offset losses from the drop in Elevai Labs,'s long position.
The idea behind DexCom Inc and Elevai Labs, Common pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.

Other Complementary Tools

FinTech Suite
Use AI to screen and filter profitable investment opportunities
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Fundamental Analysis
View fundamental data based on most recent published financial statements
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators